ENTITY
3SBio Inc

3SBio Inc (1530 HK)

152
Analysis
Health CareChina
3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.
more
29 Jun 2025 10:15

HK Short Interest Weekly: Baba, Chow Tai Fook, Za Online, Cspc Pharma, BOC, Petrochina

We analyzed the latest HK SFC report for aggregate short position as of Jun 20th and highlight short interest changes in Baba, Chow Tai Fook, Za...

Logo
410 Views
Share
29 Jun 2025 09:19

China Healthcare Weekly (Jun.29) - Biotech Valuation Bubble Is About to Burst, Innovent's Placement

The valuation bubble of innovative drug companies may burst soon, with some founders/shareholders already cashing out. Innovent's Placing Price of...

Logo
425 Views
Share
23 Jun 2025 12:48Syndicated

Chinese Biotech Innovators Push Overseas as Sector Faces Reckoning

After years of falling valuations and stalled IPO activity, China’s innovative drug industry is showing early signs of a comeback. A spate of...

Logo
293 Views
Share
22 Jun 2025 10:10

HK Short Interest Weekly: Beke, Zijin Mining, Wuxi Apptec, AIA, Tencent, BYD, Li Auto

We analyzed the latest HK SFC report for aggregate short position as of Jun 13th and highlight short interest changes in Beke, Zijin Mining, Wuxi...

Logo
554 Views
Share
17 Jun 2025 14:34Syndicated

CX Daily: Chinese Biotech Is Having a ‘DeepSeek Moment’

Drugs / Cover Story: Chinese biotech is having a ‘deepseek moment’ Hong Kong /: Hong Kong bets on stablecoins and AI to future-proof its financial...

Logo
386 Views
Share
x